Alzheimer ‘s disease |
• Increased ROS production [26, 27] |
• Impaired balance of mitochondrial fission and fusion [8, 28–31] |
• Aberrant mitochondrial enzymes [32–35] |
• Increased mtDNA mutation [36] |
• Abnormal function of mitochondrial import channels [37] |
• Inflammation [38, 39] |
• Accumulation of APP/Aβ in mitochondrial import channels [37] |
• Mitochondrial dysfunction-induced apoptosis [6, 40, 41] |
• Impaired Na+/Ca2+ exchanger (mitochondrial Ca2+ overload) [42–44] |
• Impaired mitochondrial trafficking [45–47] |
• Mitophagy defects [48, 49] |
Traumatic Brain Injury |
• Decreased mitochondrial membrane potential [50] |
• Mitochondrial Ca2+ overload [50, 51] |
• Reduced oxidase complex activity [52] |
• Imbalance of mitochondrial fusion and fission induced mitochondrial respiration dysfunction, increased ROS production, and release of apoptosis- related factors [53–57] |
• Impaired mitopahgy [58] |
Stroke |
• Failure of membrane ion pump, cellular potassium efflux, sodium influx, and the depolarization of the membrane [59–61] |
• The dysregulation of mitochondrial Ca2+ homeostasis [62–64] |
• Cytochrome c release induced apoptosis [65, 66] |
• Excessive mitochondrial superoxide production [67–69] |
• Mitochondrial dynamics defects [70–74] |
• Abnormal mitophagy [75–77] |
Depression |
• Inhibition of mitochondrial OXPHOS activity [78] |
• Decreased content of mitochondrial enzymes [79, 80] |
• Inhibition of complexes in the mitochondrial respiratory chain and the activity of Na+, K + -ATPase [81–85] |
• Increased mtDNA mutation [78, 86, 87] |
• Impaired mitochondrial ETC [78, 88, 89] |
Parkinson’s disease |
• Mitochondrial respiration defects [90, 91] |
• Genetic mutation induced mitochondrial dysfunction [92–95] |
• Excessive ROS production [90, 96, 97] |
• Mitochondrial dynamics defects [98–100] |
• Mitochondrial Ca2+ overload in DA neurons [101, 102] |
• Inappropriate trafficking of damaged mitochondria [103] |
• Compromised mitophagy [104] |